Issued 2026-09-25 at $3.34 · now $3.34 (2026-09-25, +0.0% since)
Based on its own history, a month from the 2026-09-25 close, MNKD has typically landed between $2.70 and $4.24 — a range of −19.2% to +27.0% from the issuance price $3.34.
- Actual close
- Typical path (median)
- Middle 50% of outcomes
- 90% range
5,008 overlapping 1 month windows · 2006-09-26 – 2026-08-26 · basis climatology · forecast (batch). Base rate up 53.7% (90% CI 51.5–55.9%, ≈1,391 obs). Not a call on this stock — we have no evidence its odds differ.
The cone is anchored at the 2026-09-25 issuance close ($3.34) — the price the forecast resolves against on 2026-10-26, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.
Where MNKD has typically landed a month from the 2026-09-25 close of $3.34 — the range is history, not a prediction.
- now $3.34 (+0.0%)
- typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $3.32 (-0.7%)
- middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $3.01–$3.62
- 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $2.7–$4.24
| Start | Return | Max drop | Max rise |
|---|---|---|---|
| 3 worst | |||
| 2008-03-24 | −65.5% | −66.6% | +3.8% |
| 2008-03-27 | −65.2% | −67.6% | +0.8% |
| 2008-03-26 | −64.0% | −66.3% | +4.8% |
| 3 best | |||
| 2017-09-11 | +228.9% | −9.3% | +228.9% |
| 2017-09-08 | +169.2% | −6.6% | +169.2% |
| 2017-09-07 | +154.0% | −6.6% | +154.0% |
5,008 overlapping windows · 2006-09-26 – 2026-09-25 · not cherry-picked
Pending catalysts
- March 2027 — Trial primary completion: Phase 2 primary completion: INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes (source, as of 2026-08-14)
- 2028-01-30 — Trial primary completion: Phase 2 primary completion: Phase 2 Clinical Trial of MNKD-201 (Nintedanib Dry Powder Inhalation) in Patients With Idiopathic Pulmonary Fibrosis (source, as of 2026-08-14)
Public, scheduled events — dated attention, not a prediction of the outcome. See the FDA catalysts page for the historical base rate.
Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.
iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~20 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.Up-frequency and average month-over-month return · historical frequency, not a prediction
Reported insider & political trades
Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.
| Date | Person | Role | Action | Shares @ price | Value | Ownership Δ | vs S&P 1m | vs S&P 6m | Owned after | Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-10 | Binder Steven B. | director | Sale | 33,558 @ $3.81 | $128K | −4.3% of holding | not yet — horizon still open | not yet — horizon still open | 752,309 | Form 4 · filed 4 days after the trade |
| 2026-08-07 | Binder Steven B. | director | Sale | 39,051 @ $4.06 | $159K | −4.7% of holding | +2.2% | not yet — horizon still open | 785,867 | Form 4 · filed 3 days after the trade |
| 2026-07-17 | Binder Steven B. | director | Sale | 52,485 @ $4.06 | $213K | −6.0% of holding | −7.2% | not yet — horizon still open | 824,918 | Form 4 · filed same day |
| 2026-07-17 | Thomson David | officer | Sale | 24,109 @ $4.05 | $98K | −2.9% of holding | −7.2% | not yet — horizon still open | 797,554 | Form 4 · filed same day |
| 2026-05-12 | Binder Steven B. | director | Sale | 16,940 @ $3.29 | $56K | −2.1% of holding | +14.4% | not yet — horizon still open | 808,008 | Form 4 · filed 1 day after the trade |
| 2026-05-12 | Thomson David | officer | Sale | 3,033 @ $3.29 | $10K | −0.4% of holding | +14.4% | not yet — horizon still open | 826,299 | Form 4 · filed 1 day after the trade |
| 2026-03-10 | Castagna Michael | director | Purchase | 100,000 @ $2.59 | $259K | +4.0% of holding | −2.6% | +37.8% | 2,575,911 | Form 4 · filed same day |
| 2026-01-08 | Tross Stuart A | officer | Sale | 47,006 @ $6.33 | $298K | −4.6% of holding | −2.3% | −42.0% | 985,007 | Form 4 · filed 1 day after the trade |
| 2025-12-17 | Castagna Michael | director | Sale | 65,804 @ $6.01 | $395K | −2.6% of holding | −9.3% | −46.6% | 2,504,792 | Form 4 · filed 2 days after the trade |
| 2025-12-16 | Castagna Michael | director | Sale | 21,310 @ $6.00 | $128K | −0.8% of holding | −14.0% | −44.2% | 2,504,792 | Form 4 · filed same day |
| 2025-12-12 | Castagna Michael | director | Sale | 20,806 @ $6.00 | $125K | −0.8% of holding | −7.1% | −45.5% | 2,504,792 | Form 4 · filed 4 days after the trade |
| 2025-12-02 | Thomson David | officer | Sale | 147,780 @ $5.57 | $823K | −14.9% of holding | −0.4% | −48.7% | 841,719 | Form 4 · filed 2 days after the trade |
| 2025-12-02 | Castagna Michael | director | Sale | 107,920 @ $5.57 | $601K | −4.1% of holding | −0.4% | −48.7% | 2,504,792 | Form 4 · filed 2 days after the trade |
| 2025-11-14 | Singh Sanjay R | officer | Sale | 18,777 @ $5.03 | $94K | −4.0% of holding | +15.8% | −51.3% | 455,211 | Form 4 · filed same day |
| 2025-09-16 | Tross Stuart A | officer | Sale | 47,000 @ $5.34 | $251K | −4.4% of holding | −3.7% | −52.2% | 1,032,013 | Form 4 · filed 1 day after the trade |
| 2025-07-16 | Binder Steven B. | director | Sale | 75,367 @ $3.94 | $297K | −8.3% of holding | −9.9% | +30.4% | 830,508 | Form 4 · filed 1 day after the trade |
| 2025-07-16 | Thomson David | officer | Sale | 7,466 @ $3.94 | $29K | −0.9% of holding | −9.9% | +30.4% | 841,719 | Form 4 · filed 1 day after the trade |
| 2025-06-10 | Binder Steven B. | director | Sale | 64,085 @ $4.00 | $256K | −6.5% of holding | −7.5% | +33.3% | 925,258 | Form 4 · filed same day |
| 2025-05-20 | Binder Steven B. | director | Sale | 12,078 @ $4.40 | $53K | −1.2% of holding | −14.1% | +4.1% | 989,343 | Form 4 · filed same day |
| 2025-05-20 | Thomson David | officer | Sale | 2,345 @ $4.41 | $10K | −0.3% of holding | −14.1% | +4.1% | 879,546 | Form 4 · filed same day |
| 2025-05-13 | Binder Steven B. | director | Sale | 80,144 @ $4.69 | $376K | −7.4% of holding | −21.7% | −5.8% | 1,006,611 | Form 4 · filed 2 days after the trade |
| 2025-05-13 | Thomson David | officer | Sale | 32,179 @ $4.68 | $151K | −4.0% of holding | −21.7% | −5.8% | 772,427 | Form 4 · filed 2 days after the trade |
| 2024-11-22 | Binder Steven B. | director | Sale | 67,536 @ $6.89 | $465K | −5.9% of holding | −2.8% | −39.5% | 1,075,026 | Form 4 · filed 3 days after the trade |
| 2024-11-15 | Binder Steven B. | director | Sale | 67,539 @ $6.76 | $457K | −5.9% of holding | −16.0% | −38.8% | 1,075,026 | Form 4 · filed 4 days after the trade |
| 2024-11-06 | Tross Stuart A | officer | Sale | 55,000 @ $7.34 | $404K | −5.4% of holding | −11.4% | −34.6% | 967,191 | Form 4 · filed 2 days after the trade |
| 2024-09-03 | Tross Stuart A | officer | Sale | 25,000 @ $6.26 | $157K | −2.4% of holding | +0.1% | −23.5% | 1,022,191 | Form 4 · filed 1 day after the trade |
| 2024-08-30 | Tross Stuart A | officer | Sale | 45,000 @ $6.33 | $285K | −4.0% of holding | −1.2% | −21.8% | 1,082,191 | Form 4 · filed same day |
| 2024-08-30 | Tross Stuart A | officer | Sale | 35,000 @ $6.32 | $221K | −3.2% of holding | −1.2% | −21.8% | 1,047,191 | Form 4 · filed same day |
| 2024-08-29 | Castagna Michael | director | Sale | 85,106 @ $6.30 | $536K | −3.6% of holding | −3.7% | −22.6% | 2,294,836 | Form 4 · filed same day |
| 2024-08-29 | Thomson David | officer | Sale | 5,553 @ $5.94 | $33K | −0.7% of holding | −3.7% | −22.6% | 829,843 | Form 4 · filed same day |
| 2024-08-29 | Binder Steven B. | director | Sale | 5,055 @ $5.94 | $30K | −0.5% of holding | −3.7% | −22.6% | 1,075,026 | Form 4 · filed same day |
| 2024-07-16 | Thomson David | officer | Sale | 3,115 @ $5.93 | $18K | −0.4% of holding | −9.8% | −4.5% | 857,885 | Form 4 · filed 1 day after the trade |
| 2024-07-16 | Binder Steven B. | director | Sale | 2,836 @ $5.93 | $17K | −0.3% of holding | −9.8% | −4.5% | 1,100,860 | Form 4 · filed 1 day after the trade |
| 2024-05-21 | Binder Steven B. | director | Sale | 25,952 @ $4.66 | $121K | −2.3% of holding | +5.0% | +32.9% | 1,114,553 | Form 4 · filed same day |
| 2024-05-21 | Thomson David | officer | Sale | 23,537 @ $4.66 | $110K | −2.6% of holding | +5.0% | +32.9% | 873,616 | Form 4 · filed same day |
| 2024-05-13 | Binder Steven B. | director | Sale | 3,618 @ $4.31 | $16K | −0.4% of holding | +3.3% | +48.1% | 845,967 | Form 4 · filed 1 day after the trade |
| 2024-05-13 | Thomson David | officer | Sale | 3,047 @ $4.31 | $13K | −0.4% of holding | +3.3% | +48.1% | 783,446 | Form 4 · filed 1 day after the trade |
The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.
217 award / exercise / gift records — not counted as purchases
Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.
| Date | Person | Role | Action | Shares | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-07-15 | Castagna Michael | director | Withheld for tax | 192,819 | 2,604,160 | Form 4 |
| 2026-07-15 | Castagna Michael | director | Withheld for tax | 63,996 | 2,492,683 | Form 4 |
| 2026-07-15 | Castagna Michael | director | Withheld for tax | 58,904 | 2,433,779 | Form 4 |
| 2026-07-15 | Thomson David | officer | Withheld for tax | 51,632 | 868,457 | Form 4 |
| 2026-07-15 | Castagna Michael | director | Withheld for tax | 47,481 | 2,556,679 | Form 4 |
| 2026-07-15 | Tross Stuart A | officer | Withheld for tax | 33,652 | 1,090,298 | Form 4 |
| 2026-07-15 | Singh Sanjay R | officer | Withheld for tax | 22,047 | 503,714 | Form 4 |
| 2026-07-15 | Thomson David | officer | Withheld for tax | 17,754 | 838,041 | Form 4 |
| 2026-07-15 | Thomson David | officer | Withheld for tax | 16,378 | 821,663 | Form 4 |
| 2026-07-15 | Binder Steven B. | director | Withheld for tax | 15,688 | 886,110 | Form 4 |
| 2026-07-15 | Thomson David | officer | Withheld for tax | 12,662 | 855,795 | Form 4 |
| 2026-07-15 | Tross Stuart A | officer | Withheld for tax | 12,331 | 1,058,142 | Form 4 |
| 2026-07-15 | Tross Stuart A | officer | Withheld for tax | 11,572 | 1,070,473 | Form 4 |
| 2026-07-15 | Prentiss Christopher B | officer | Withheld for tax | 11,572 | 329,343 | Form 4 |
| 2026-07-15 | Prentiss Christopher B | officer | Withheld for tax | 10,675 | 318,668 | Form 4 |
| 2026-07-15 | Singh Sanjay R | officer | Withheld for tax | 10,079 | 488,263 | Form 4 |
| 2026-07-15 | Singh Sanjay R | officer | Withheld for tax | 9,297 | 478,966 | Form 4 |
| 2026-07-15 | Tross Stuart A | officer | Withheld for tax | 8,253 | 1,082,045 | Form 4 |
| 2026-07-15 | Singh Sanjay R | officer | Withheld for tax | 5,372 | 498,342 | Form 4 |
| 2026-07-15 | Binder Steven B. | director | Withheld for tax | 4,634 | 877,403 | Form 4 |
| 2026-07-15 | Binder Steven B. | director | Withheld for tax | 4,073 | 882,037 | Form 4 |
| 2026-07-15 | Marasco Dominic | officer | Withheld for tax | 3,623 | 343,398 | Form 4 |
| 2026-07-15 | Tross Stuart A | officer | Option exercise | 93,790 | 1,123,950 | Form 4 |
| 2026-07-15 | Thomson David | officer | Option exercise | 93,790 | 920,089 | Form 4 |
| 2026-07-15 | Castagna Michael | director | Option exercise | 350,260 | 0 | Form 4 |
| 2026-07-15 | Binder Steven B. | director | Option exercise | 93,790 | 901,798 | Form 4 |
| 2026-07-15 | Tross Stuart A | officer | Option exercise | 93,790 | 0 | Form 4 |
| 2026-07-15 | Binder Steven B. | director | Option exercise | 93,790 | 0 | Form 4 |
| 2026-07-15 | Castagna Michael | director | Option exercise | 350,260 | 2,796,979 | Form 4 |
| 2026-07-15 | Singh Sanjay R | officer | Option exercise | 70,550 | 525,761 | Form 4 |
| 2026-07-15 | Thomson David | officer | Option exercise | 93,790 | 0 | Form 4 |
| 2026-07-15 | Singh Sanjay R | officer | Option exercise | 70,550 | 0 | Form 4 |
| 2026-05-20 | Tross Stuart A | officer | Award / grant | 33,898 | 1,026,122 | Form 4 |
| 2026-05-20 | Consiglio Ronald J | director | Award / grant | 10,000 | 132,342 | Form 4 |
| 2026-05-20 | Marasco Dominic | officer | Award / grant | 8,474 | 344,246 | Form 4 |
| 2026-05-20 | Shannon James Samuel | director | Award / grant | 82,781 | 82,781 | Form 4 |
| 2026-05-20 | Friedman Michael A | director | Award / grant | 82,781 | 82,781 | Form 4 |
| 2026-05-20 | Consiglio Ronald J | director | Award / grant | 82,781 | 82,781 | Form 4 |
| 2026-05-20 | Consiglio Ronald J | director | Award / grant | 16,556 | 16,556 | Form 4 |
| 2026-05-20 | HOOPER ANTHONY C | director | Award / grant | 82,781 | 82,781 | Form 4 |
Source: SEC Form 4 filings. Each row links to its original filing.
Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.
Congressional disclosures
No congressional trades disclosed for this company.
Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.